Literature DB >> 27255605

Optimizing nutrient channel spacing and revisiting TGF-beta in large engineered cartilage constructs.

Alexander D Cigan1, Robert J Nims1, Gordana Vunjak-Novakovic1, Clark T Hung1, Gerard A Ateshian2.   

Abstract

Cartilage tissue engineering is a promising approach to treat osteoarthritis. However, current techniques produce tissues too small for clinical relevance. Increasingly close-packed channels have helped overcome nutrient transport limitations in centimeter-sized chondrocyte-agarose constructs, yet optimal channel spacings to recapitulate native cartilage compositional and mechanical properties in constructs this large have not been identified. Transient active TGF-β treatment consistently reproduces native compressive Young׳s modulus (EY) and glycosaminoglycan (GAG) content in constructs, but standard dosages of 10ng/mL exacerbate matrix heterogeneity. To ultimately produce articular layer-sized constructs, we must first optimize channel spacing and investigate the role of TGF-β in the utility of channels. We cultured ∅10mm constructs with 0, 12, 19, or 27 nutrient channels (∅1mm) for 6-8 weeks with 0, 1, or 10ng/mL TGF-β; subsequently we analyzed them mechanically, biochemically, and histologically. Constructs with 12 or 19 channels grew the most favorably, reaching EY=344±113kPa and GAG and collagen contents of 10.8±1.2% and 2.2±0.2% of construct wet weight, respectively. Constructs with 27 channels had significantly less deposited GAG than other groups. Channeled constructs given 1 or 10ng/mL TGF-β developed similar properties. Without TGF-β, constructs with 0 or 12 channels exhibited properties that were indistinguishable, and lower than TGF-β-supplemented constructs. Taken together, these results emphasize that nutrient channels are effective only in the presence of TGF-β, and indicate that spacings equivalent to 12 channels in ∅10mm constructs can be employed in articular-layer-sized constructs with reduced dosages of TGF-β.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Agarose; Cartilage; Chondrocytes; Growth factors; Nutrient transport; Tissue engineering

Mesh:

Substances:

Year:  2016        PMID: 27255605      PMCID: PMC4922491          DOI: 10.1016/j.jbiomech.2016.05.020

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  33 in total

1.  Human chondrocyte migration behaviour to guide the development of engineered cartilage.

Authors:  Grace D O'Connell; Andrea R Tan; Victoria Cui; J Chloe Bulinski; James L Cook; Mukundan Attur; Steven B Abramson; Gerard A Ateshian; Clark T Hung
Journal:  J Tissue Eng Regen Med       Date:  2015-01-28       Impact factor: 3.963

Review 2.  Tissue engineering.

Authors:  R Langer; J P Vacanti
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

3.  Insulin, ascorbate, and glucose have a much greater influence than transferrin and selenous acid on the in vitro growth of engineered cartilage in chondrogenic media.

Authors:  Alexander D Cigan; Robert J Nims; Michael B Albro; John D Esau; Marissa P Dreyer; Gordana Vunjak-Novakovic; Clark T Hung; Gerard A Ateshian
Journal:  Tissue Eng Part A       Date:  2013-05-30       Impact factor: 3.845

4.  Nutrient channels and stirring enhanced the composition and stiffness of large cartilage constructs.

Authors:  Alexander D Cigan; Robert J Nims; Michael B Albro; Gordana Vunjak-Novakovic; Clark T Hung; Gerard A Ateshian
Journal:  J Biomech       Date:  2014-10-23       Impact factor: 2.712

5.  Electrostatic and non-electrostatic contributions of proteoglycans to the compressive equilibrium modulus of bovine articular cartilage.

Authors:  Clare Canal Guterl; Clark T Hung; Gerard A Ateshian
Journal:  J Biomech       Date:  2010-02-26       Impact factor: 2.712

6.  Functional properties of cell-seeded three-dimensionally woven poly(epsilon-caprolactone) scaffolds for cartilage tissue engineering.

Authors:  Franklin T Moutos; Farshid Guilak
Journal:  Tissue Eng Part A       Date:  2010-04       Impact factor: 3.845

7.  Engineering of large cartilaginous tissues through the use of microchanneled hydrogels and rotational culture.

Authors:  Conor T Buckley; Stephen D Thorpe; Daniel J Kelly
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

8.  Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay.

Authors:  A P Hollander; T F Heathfield; C Webber; Y Iwata; R Bourne; C Rorabeck; A R Poole
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  Inhomogeneous cartilage properties enhance superficial interstitial fluid support and frictional properties, but do not provide a homogeneous state of stress.

Authors:  Ramaswamy Krishnan; Seonghun Park; Felix Eckstein; Gerard A Ateshian
Journal:  J Biomech Eng       Date:  2003-10       Impact factor: 2.097

10.  Influence of decreasing nutrient path length on the development of engineered cartilage.

Authors:  L Bian; S L Angione; K W Ng; E G Lima; D Y Williams; D Q Mao; G A Ateshian; C T Hung
Journal:  Osteoarthritis Cartilage       Date:  2008-10-17       Impact factor: 6.576

View more
  3 in total

1.  * Constrained Cage Culture Improves Engineered Cartilage Functional Properties by Enhancing Collagen Network Stability.

Authors:  Robert J Nims; Alexander D Cigan; Krista M Durney; Brian K Jones; John D O'Neill; Wing-Sum A Law; Gordana Vunjak-Novakovic; Clark T Hung; Gerard A Ateshian
Journal:  Tissue Eng Part A       Date:  2017-03-27       Impact factor: 3.845

2.  Enhanced nutrient transport improves the depth-dependent properties of tri-layered engineered cartilage constructs with zonal co-culture of chondrocytes and MSCs.

Authors:  Minwook Kim; Megan J Farrell; David R Steinberg; Jason A Burdick; Robert L Mauck
Journal:  Acta Biomater       Date:  2017-06-16       Impact factor: 8.947

3.  Engineering large cartilage tissues using dynamic bioreactor culture at defined oxygen conditions.

Authors:  Andrew C Daly; Binulal N Sathy; Daniel J Kelly
Journal:  J Tissue Eng       Date:  2018-01-24       Impact factor: 7.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.